Latest papers

[An unusual presentation of progressive multifocal leukoencephalopathy as contrast enhanced lesion]

A sense of insecurity.

Therapy: Targeted but not trouble-free: efalizumab and PML.

Immunosuppressants: JC virus encephalopathy. Rare but fatal.

JC Virus: An oncogenic virus in animals and humans?

[Molecular target drug development for curing multiple sclerosis]

A mechanism-based classification of dermatologic reactions to biologic agents used in the treatment of cutaneous disease: Part 1.

JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy

Progressive multifocal leukoencephalopathy in autoimmune disorders.

[Case of optic neuritis associated with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL)].

Mirtazapine in an HIV-1 infected patient with progressive multifocal leukoencephalopathy.

Patient fatalities potentially associated with efalizumab use.

Images in HIV/AIDS. Fatal progressive multifocal leukoencephalopathy: still a problem in the era of highly active antiretroviral therapy.

[Cerebral aspergillosis in an HIV-infected patient: unsuccessful outcome despite combined antifungal therapy. ].

Progressive multifocal leuconcephalopathy and autoimmune haemolytic anemia in chronic lymphocytic leukaemia: more than a fortuitous combination?

[Multifocal progressive leukoencephalitis: radiologic aspects].

Multiple roles for Puralpha in cellular and viral regulation.

Follow-up magnetic resonance imaging findings in patients with progressive multifocal leukoencephalopathy: evaluation of long-term survivors under highly active antiretroviral therapy.

Effective use of JC virus PCR for diagnosis of progressive multifocal leukoencephalopathy

Efficient in vitro expansion of JC virus-specific CD8(+) T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy.